idarucizumab
idarucizumab is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand name including Praxbind. Available dosage forms: injection, liquid.
Drug Details
- Generic Name
- idarucizumab
- Brand Names
- Praxbind
- Application Number
- BLA761025
- Sponsor
- Boehringer Ingelheim Pharmaceuticals, Inc.
- NDC Codes
- 3
- Dosage Forms
- INJECTION, LIQUID
- Routes
- INTRAVENOUS
- Active Ingredients
- IDARUCIZUMAB
Indications and Usage
1 INDICATIONS AND USAGE PRAXBIND is indicated in patients treated with Pradaxa when reversal of the anticoagulant effects of dabigatran is needed: For emergency surgery/urgent procedures In life-threatening or uncontrolled bleeding PRAXBIND is a humanized monoclonal antibody fragment (Fab) indicated in patients treated with Pradaxa ® when reversal of the anticoagulant effects of dabigatran is needed: For emergency surgery/urgent procedures In life-threatening or uncontrolled bleeding ( 1 )